Powered by

Hemostemix Provides Highlights of 2018 Accomplishments

Jan 17, 2019 - GlobeNewswire

CALGARY, Alberta, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following corporate update on accomplishments and milestones that it has achieved in 2018.  The past twelve months has seen a transformation in the Company, with a significant amount of progress made on multiple fronts, including patient and site enrollment for the current Phase II clinical trial for critical limb ischemia, manufacturin...